British Heart Foundation awards Zoll a tender for automated external defibrillators for another three-year term


On 17 July, Zoll Medical announced that it has been selected as a nominated supplier by the British Heart Foundation (BHF) for the Zoll AED Plus through 2016.

Zoll has been working in partnership with the BHF since 2010 to supply the AED Plus through their part-funding programme, which recommends the device to communities and organisations requesting funding for automated external defibrillators and offers it at a discounted rate. Zoll has supplied numerous automated external defibrillators to public places and areas of need throughout the United Kingdom in conjunction with its existing partnership with the BHF.

The tender process involves leading professionals from both the medical community and ambulance service who scrutinise all aspects vital to the delivery of BHF’s community resuscitation work. The clinical aspects of the devices, account management, compliance with resuscitation guidelines, and compatibility with the ambulance services are all taken into account.

Sarah Forsey, Grants and Awards Manager at the BHF, said, “Less than 10% of the 30,000 people that suffer a cardiac arrest outside of hospital live long enough to leave hospital alive. But many of these lives could be saved if more defibrillators were available in public places. Since 1996 the BHF has placed more than 9,500 defibrillators around the UK, many of which have been used in an emergency. We are therefore delighted to be continuing our relationship with Zoll as we work to make more automated external defibrillators readily available in UK communities.”

“Over the last three years, we have seen consistent growth in the automated external defibrillators market in the United Kingdom with communities and businesses beginning to realise the importance of these life-saving devices. This market will continue to grow and we are looking forward to the next three years working in partnership with the British Heart Foundation in helping to save lives from sudden cardiac arrest,” said Jonathan A Rennert, president of Zoll.